|
Distributions of SCAP and SREBF-2 genotypes among men with SCD, AMI, thrombosis and complicated lesions (CL), and among those who had not suffered from the same at the time of death |
|||||||||
| Genotype |
N (%) |
N (%) |
N (%) |
N (%) |
|||||
| SCAP |
SREBF-2 |
SCD |
Non-SCD |
With CL |
Without CL |
Thrombus |
Without thrombus |
AMI |
Non-AMI |
|
|
|||||||||
| AA |
GC+CC |
8 (8.4) |
26 (17.1) |
8 (8.8) |
26 (16.7) |
2 (10.0) |
32 (14.1) |
4 (14.3) |
30 (13.7) |
| GG |
21 (22.1) |
30 (19.7) |
18 (19.8) |
33 (21.2) |
2 (10.0) |
49 (21.6) |
3 (10.7) |
48 (21.9) |
|
| AG+GG |
GC+CC |
33 (34.7) |
40 (26.3) |
31 (34.1) |
42 (26.9) |
8 (40.0) |
65 (28.6) |
11 (39.3) |
62 (28.3) |
| GG |
33 (34.7) |
56 (36.8) |
34 (37.4) |
55 (35.3) |
8 (40.0) |
81 (35.7) |
10 (35.7) |
79 (36.1) |
|
|
Values are n (%). Abbreviations: AMI, acute myocardial infarction; CL, complicated lesions; SCD, sudden cardiac death. | |||||||||
Fan et al. Thrombosis Journal 2008 6:17 doi:10.1186/1477-9560-6-17 |
|||||||||